Global Thrombosis And Hemostasis Biomarkers Market Size & Outlook
The thrombosis and hemostasis biomarkers industry worldwide is expected to reach a projected revenue of US$ 7,918.2 million by 2030. A compound annual growth rate of 5.9% is expected of the worldwide thrombosis and hemostasis biomarkers industry from 2023 to 2030.
Revenue, 2022 (US$M)
$5,007.5
Forecast, 2030 (US$M)
$7,918.2
CAGR, 2023 - 2030
5.9%
Report Coverage
Worldwide
Global thrombosis and hemostasis biomarkers market, 2018-2030 (US$M)
Related Markets
Global thrombosis and hemostasis biomarkers market highlights
- The global thrombosis and hemostasis biomarkers market generated a revenue of USD 5,007.5 million in 2022 and is expected to reach USD 7,918.2 million by 2030.
- The market is expected to grow at a CAGR (2023 - 2030) of 5.9% by 2030.
- In terms of segment, reagents & consumables accounted for a revenue of USD 3,275.2 million in 2022.
- Reagents & Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2022.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 5,007.5 million |
| Market revenue in 2030 | USD 7,918.2 million |
| Growth rate | 5.9% (CAGR from 2022 to 2030) |
| Largest segment | Reagents & consumables |
| Fastest growing segment | Reagents & Consumables |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Analyzers, Reagents & Consumables |
Other key industry trends
- In terms of revenue, the North America accounted for 37.0% of the global thrombosis and hemostasis biomarkers market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Saudi Arabia is the fastest growing regional market and is projected to reach USD 76.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Thrombosis And Hemostasis Biomarkers Market Scope
Thrombosis and hemostasis biomarkers market segmentation & scope
D-Dimer
Anti-Thrombin III
Plasminogen
Soluble Fibrin
Selectins
Factor VIII
PT
APTT
Fibrinogen
Others
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Disseminated Intravascular Coagulation (DIC)
Others
Thrombosis And Hemostasis Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global thrombosis and hemostasis biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thrombosis and hemostasis biomarkers market will help companies and investors design strategic landscapes.
reagents & consumables was the largest segment with a revenue share of 65.41% in 2022. Horizon Databook has segmented the Global thrombosis and hemostasis biomarkers market based on analyzers, reagents & consumables covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Thrombosis And Hemostasis Biomarkers Product Outlook (Revenue, USD Million, 2018-2030)
- Analyzers
- Reagents & Consumables
- Global Thrombosis And Hemostasis Biomarkers Test Location Outlook (Revenue, USD Million, 2018-2030)
- Clinical Laboratory Tests
- Point-of-Care Tests
- Global Thrombosis And Hemostasis Biomarkers Test Type Outlook (Revenue, USD Million, 2018-2030)
- D-Dimer
- Anti-Thrombin III
- Plasminogen
- Soluble Fibrin
- Selectins
- Factor VIII
- PT
- APTT
- Fibrinogen
- Others
- Global Thrombosis And Hemostasis Biomarkers Application Outlook (Revenue, USD Million, 2018-2030)
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Disseminated Intravascular Coagulation (DIC)
- Others
- Global Thrombosis And Hemostasis Biomarkers End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Clinics
- Academic & Research Institutes
- Diagnostic Centers
- Others
Reasons to subscribe to Global thrombosis and hemostasis biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global thrombosis and hemostasis biomarkers market databook
-
Our clientele includes a mix of thrombosis and hemostasis biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global thrombosis and hemostasis biomarkers market , including forecasts for subscribers. This global databook contains high-level insights into Global thrombosis and hemostasis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global thrombosis and hemostasis biomarkers market statistics, by regions, 2018-2030 (US$M)
Top 10 countries: Thrombosis and hemostasis biomarkers market size, 2022 (USD Million)
Top 10 countries: Thrombosis and hemostasis biomarkers market size, 2022 (USD Million)
Global thrombosis and hemostasis biomarkers market, by region, 2022 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
